2022-03-28 648
Beautech Healthcare is a medical anti-aging institution invested by CITIC PE, which integrates international most advanced medical technology resources and top medical expert team in domestic and abroad. Outstanding clinical medical experts and technical R & D scientific researchers from Germany, Japan, South Korea and Taiwan are gathered in Beautech Healthcare to provide you with precise medical treatment and individualized health management with taking geroscience as the core technologies.
Beautech Healthcare is different from conventional hospitals. It is not only to "diagnose the disease and treat the disease", but also to "pay attention to the evolution of the disease and prevent the occurrence of the disease". This idea is derived from geroscience, which emphasizes that the duration and proportion of a person's health can be prolonged as long as possible through compressing or reducing the time and proportion of onset. The concept was first proposed by James F Fries, a professor at Stanford University School of Medicine, in 1980, and has become a focus of Chinese immunologists since it was introduced to China in 2012. Since then, Beautech Healthcare has also become one of the few tertiary general hospitals in China that take geroscience research and application as its guiding ideology.
Through the application of integrated medical technology, including functional medicine, biotechnology, sports medicine, etc., the Beautech Healthcare is devoted to the management of sub-health conditioning and intervention of chronic / metabolic / degenerative diseases. It is committed to providing customers with overall health management, disease prevention with providing customers with high quality health care services. Beautech Stem Cell Anti-aging Hospital includes internal medicine department (Hematology), surgery department, gynecology and Obstetrics department (Gynecology), medical cosmetology department, anesthesiology department, medical laboratory department (clinical body fluid and blood examination), medical imaging department (ultrasound diagnosis), and traditional Chinese medicine department, equipped with intelligent cell cryopreservation equipment and automatic preparation laboratory. In addition, it also provides R & D, technical consultation and technical services of cell biotechnology.
Beautech Healthcare has established leading innovative storage systems in the field of sample deep detection gene identification, intelligent profound hypothermia storage system, automatic remote backup storage, digital remote unified management system, and provides fully automated immune cell storage and management solutions. At the same time, Beautech Healthcare has a multi-functional cell laboratory in line with GMP standards, including independent cell preparation area, independent cell quality control area, cryopreservation, research and experimental area, etc. The whole cell laboratory has four characteristics of "fully independent, ultra-clean, multi-functional and full monitoring", which provides an environmental basis for the preparation and research of various cells.
Randy W. Schekman, the laureate of 2013 Nobel Prize in Physiology or Medicine, jointly established the Nobel Prize Workstation with Beautech Healthcare. Randy W. Schekman, as the chief academic advisor and honorary dean, served as the director of Nobel Prize Workstation to strengthen international medical exchanges and cooperation, and guide the translational research in the field of geroscience.
Under the policy support of Hainan Boao Lecheng international medical tourism pilot zone, Beautech Healthcare reached long-term close cooperation with the international leading pharmaceutical institutions, successfully introduced a number of innovative medicine and medical apparatus and instruments. Since establishment, many global leading pharmaceutical companies such as Braun, Thermo Fisher, Novartis and Arthrex have successfully joined hands with Beautech Healthcare, constantly refreshing the new height of medical application in China. Meanwhile, a number of domestic authorities in the field of cell have also reached long-term strategic partnership with Beautech Healthcare, such as Shanghai Zhangjiang Biobank and Shanghai Cell Therapy Group. All of us will look far into the future during research and gradually increase the investment in expert resources, equipment, experimental environment and other aspects, committed to provide accurate comprehensive treatment means of chronic disease management, cancer prevention, delaying the decline of body function and other aspects for Chinese people .